| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-11 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-08 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-06 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-06 |